1887

Journal of General Virology header logo

Volume 77, Issue 4

Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly Free

Abstract

Seven internal deletions within the p24 domain of the human immunodeficiency virus type 1 Gag precursor have been assessed for their effect on Gag particle formation following their expression using recombinant baculoviruses. In addition, each deleted molecule was assessed for its ability to bind soluble p24 antigen . The mutants fell into three different phenotypic groups: (i) three mutants that had no effect on either p24 binding or Gag particle assembly, (ii) three mutants that abolished both features and (iii) one mutant that bound p24 but failed to assemble particles. Mutations that abolished both p24 binding and particle assembly mapped to the C terminus of p24 confirming this region as critical for virion assembly. We suggest the division of virion assembly into at least two distinct phases and suggest a model in which the critical sequences mapped to date are combined with available structural information.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1996
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-4-743
1996-04-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/4/JV0770040743.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-4-743&mimeType=html&fmt=ahah

References

  1. Carriere C., Gay B., Chazal N., Morin N., Boulanger P. 1995; Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles. Journal of Virology 69:2366–2377
     [Google Scholar]
  2. Chazal N., Carriere H. B., Gay B, Boulanger P. 1994; Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 gag precursor expressed in recombinant baculovirus-infected cells. Journal of Virology 68:111–122
     [Google Scholar]
  3. Chazal N., Gay B., Carriers C., Tournier J., Boulanger P. 1995; Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and transeffects on Gag precursor assembly pathway. Journal of Virology 69:365–375
     [Google Scholar]
  4. Deminie C. A., Emerman M. 1993; Incorporation of human immunodeficiency virus type 1 gag proteins into murine leukemia virus virions. Journal of Virology 67:6499–6506
     [Google Scholar]
  5. Dorfman T., Bukovsky A., O’Hagen A., Hoglund S., Gott-linger H. G. 1994; Functional domains of the capsid protein of human immunodeficiency virus type 1. Journal of Virology 68:8180–8187
     [Google Scholar]
  6. Ehrlich L. S., Agresta B. E., Carter C. A. 1992; Assembly of human immunodeficiency virus type 1 capsid protein in vitro . Journal of Virology 66:4874–4883
     [Google Scholar]
  7. Ehrlich L. S., Agresta B. E., Gelfand C. A., Jentoft J., Carter C. A. 1994; Spectral analysis and tryptic susceptibility as probes of HIV-1 capsid protein structure. Virology 204:515–525
     [Google Scholar]
  8. Franke E. K., Yuan H. E., Luban J. 1994a; Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359–362
     [Google Scholar]
  9. Franke E. K., En H., Yuan H., Bossolt K. L., Goff S. P., Luban J. 1994b; Specificity and sequence requirements for interactions between various retroviral Gag proteins. Journal of Virology 68:5330–5334
     [Google Scholar]
  10. Freed E. O., Orenstein J. M., Buckler-White A. J., Martin M. A. 1994; Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. Journal of Virology 68:5311–5320
     [Google Scholar]
  11. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., Wilde M. D. 1989; Assembly and release of HIV-1 precursor pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103–112
     [Google Scholar]
  12. Gilmour J. E., Senior J. M., Burns N. R., Esnouf M. P., Gull K., Kingsman S. M., Kingsman A. J., Adams S. E. 1989; A novel method for the purification of HIV-1 p24 protein from hybrid Ty virus-like particles (Ty-VLPs). AIDS 3:717–723
     [Google Scholar]
  13. Gottlinger H. G., Dorfman T., Sodroski J. G., Haseltine W. A. 1991; Effects of mutations affecting the p6 Gag protein on human immunodeficiency virus particle release. Proceedings of the National Academy of Sciences, USA 88:3195–3199
     [Google Scholar]
  14. Grasser F. A., Sauder C., Haiss P., Hille A., Konig S., Gottel S., Kremmer E., Leinenback H. P., Zeppezauer M., Mubller-Lantzsch N. 1993; Immunological detection of proteins associated with the Epstein–Barr virus nuclear antigen 2A. Virology 195:550–560
     [Google Scholar]
  15. Hockley D. J., Nermut M. V., Grief C., Jowett J. B. M., Jones I. M. 1994; Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1. Journal of General Virology 75:2985–2997
     [Google Scholar]
  16. Hong S. S., Boulanger P. 1993; Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells. Journal of Virology 67:2787–2798
     [Google Scholar]
  17. Hoshikawa N., Kohma A., Yasuda A., Takayashiki E., Musako S., Chiba J., Sata T., Kura T. 1991; Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. Journal of General Virology 72:2501–2517
     [Google Scholar]
  18. Hu S.-L., Travis B., Garrigues J., Zarling J. M., Sridhar P., Dykers T., Eichberg J. E., Alpers C. 1990; Processing, assembly and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus. Virology 179:321–329
     [Google Scholar]
  19. Jowett J. B. M., Hockley D. J., Nermut M., Jones I. M. 1992; Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. Journal of General Virology 73:3079–3086
     [Google Scholar]
  20. Kaplan A. H., Manchester M., Swanstrom R. 1994; The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. Journal of Virology 68:6782–6786
     [Google Scholar]
  21. Kitts P., Ayres M., Possee R. 1991; Linearisation of baculovirus DNA improves the selection of recombinan t transfer vectors. Nucleic Acids Research 18:5667–5672
     [Google Scholar]
  22. Krausslich H.-G., Facke M., Heuser A.-M., Konvalinka J., Zentgraf H. 1995; The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. Journal of Virology 69:3407–3419
     [Google Scholar]
  23. Livingstone C., Jones I. M. 1989; Baculovirus expression vectors with single-strand capability. Nucleic Acids Research 17:2366
     [Google Scholar]
  24. Luban J., Lee C., Goff S. P. 1993; Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. Journal of Virology 67:3630–3634
     [Google Scholar]
  25. Mammano F., O’Hagen A., Hoglund S., Gottlinger H. G. 1994; Role of major homology region of human immunodeficiency virus type 1 in virion morphogenesis. Journal of Virology 68:4927–4936
     [Google Scholar]
  26. Massiah M. A., Starich M. R., Paschall C. M., Summers M. F., Christensen A. M., Sundquist W. I. 1994; Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. Journal of Molecular Biology 244:194–223
     [Google Scholar]
  27. Matthews S., Barlow P., Boyd J., Barton G., Russell R., Mills H., Cunningham M., Meyers N., Burns N., Clark N., Kingsman S., Kingsman A., Campbell I. 1994; Structural similarity between the pl7 matrix protein of HIV-1 and interferon gamma. Nature 370:666–668
     [Google Scholar]
  28. Mergener K., Facke M., Welker R., Brinkman V., Gelderblom H. R., Krausslich H. G. 1992; Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology 186:25–39
     [Google Scholar]
  29. Mills H. R., Jones I. M. 1990; Expression and purification of p24, the core protein of human immunodeficiency virus, using a baculovirus-insect cell expression system. AIDS 4:1125–1131
     [Google Scholar]
  30. Mills H. R., Berry N., Burns N. R., Jones I. M. 1992; Simple and efficient production of the core antigens of HIV-1, HIV-2 and simian immunodeficiency virus using pGEX expression vectors in Escherichia coli . AIDS 6:437–439
     [Google Scholar]
  31. Morikawa Y., Kishi T., Zhang W.-H., Nermut M. V., Hockley D. J., Jones I. M. 1995; A molecular determinant of HIV particle assembly located in the matrix antigen p17. Journal of Virology 69:4519–4523
     [Google Scholar]
  32. Nermut M. V., Hockley D. J., Jowett J. B. M., Jones I. M., Garreau M., Thomas D. 1994; Fullerene-like organization of HIV Gag-protein shell in virus-like particles produced by recombinant baculoviruses. Virology 198:288–296
     [Google Scholar]
  33. Niedrig M., Gelderblom H. R., Pauli G., Marz J., Bickhard H., Wolf H., Modrow S. 1994; Inhibition of infectious human immunodeficiency virus type 1 particle formation by Gag protein-derived peptides. Journal of General Virology 75:1469–1474
     [Google Scholar]
  34. O’Reilly D. R., Miller L. K., Luckow V. A. 1992 Baculovirus Expression Vectors: A Laboratory Manual 1st edn New York: W. H. Freeman;
     [Google Scholar]
  35. Overton H. A., Fujii Y., Price I. R., Jones I. M. 1989; The protease and gag gene products of the human immunodeficiency virus: authentic cleavage and post-translational modification in an insect cell expression system. Virology 170:107–116
     [Google Scholar]
  36. Paxton W., Connor R. I., Landau N. R. 1993; Incorporation of vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of Gag and mutational analysis. Journal of Virology 67:7229–7237
     [Google Scholar]
  37. Pettit S. C., Moody M. D., Wehbie R. S., Kaplan A. H., Nantermet P. V., Klein C. A., Swanstrom R. 1994; The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. Journal of Virology 68:8017–8027
     [Google Scholar]
  38. Poblotzki A. V., Wagner R., Niedrig M., Wanner G., Wolf H., Modrow S. 1993; Identification of a region in the Pr55gag polyprotein essential for HIV-1 particle formation. Virology 193:981–986
     [Google Scholar]
  39. Reicin A. S., Paik S., Berkowitz R. D., Luban J., Lowy I., Goff S. P. 1995; Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release and infectivity. Journal of Virology 69:642–650
     [Google Scholar]
  40. Royer M., Cerutti M., Gay B., Hong S.-S., Devauchblle G., Boulanger P. 1991; Functional domains of HIV-1 Gag-poly-protein expressed in baculovirus-infected insect cells. Virology 184:417–422
     [Google Scholar]
  41. Royer M., Hong S. S., Gay B., Cerutti M., Boulanger P. 1992; Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells. Journal of Virology 66:3230–3235
     [Google Scholar]
  42. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C. T., Sodroski J., Gottlinger H. G. 1994; Functional association of cyclophilin A with HIV-1 virions. Nature 372:363–365
     [Google Scholar]
  43. Trono D., Feinberg M. B., Baltimore D. 1989; HIV-1 gag mutants can dominantly interfere with the replication of the wildtype virus. Cell 59:113–120
     [Google Scholar]
  44. Veronese F. D., Copeland T. D., Oroszlan S., Gallo R. C., Sarngadharan M. G. 1988; Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. Journal of Virology 62:795–801
     [Google Scholar]
  45. Wang C. T., Barklis E. 1993; Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. Journal of Virology 67:4264–4273
     [Google Scholar]
  46. Wills J. W., Craven R. C. 1991; Form, function and use of retroviral Gag proteins. AIDS 5:639–654
     [Google Scholar]
  47. Zhang W.-H., Hockley D. J., Nermut M. V., Jones I. M. 1994; Functional consequences of mutations in HIV-1 gag p55 selected by CTL pressure. Virology 203:101–105
     [Google Scholar]
  48. Zhao Y., Jones I. M., Hockley D. J., Nermut M. V., Roy P. 1994; Complementation of human immunodeficiency virus (HIV-1) gag particle formation. Virology 199:403–408
     [Google Scholar]
  49. Zybarth G., Carter C. 1995; Domains upstream of the protease (PR) in human immunodeficiency virus type 1 gag–pol influence PR autoprocessing. Journal of Virology 69:3878–3884
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-4-743
Loading
Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly
J. Gen. Virol. 77, 743 (1996); https://doi.org/10.1099/0022-1317-77-4-743
/content/journal/jgv/10.1099/0022-1317-77-4-743
/content/journal/jgv/10.1099/0022-1317-77-4-743
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error